
JAN · NYSE
Janus Living, Inc.
$28.91 -1.14 (-3.79%)
Company overview
JanOne Inc. is a clinical-stage biopharmaceutical company that focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. Its lead product candidate is JAN101, a patented oral, sustained-release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities in patients with diabetes or peripheral artery disease to treat pain. The company was formerly known as Appliance Recycling Centers of America, Inc. and changed its name to JanOne Inc. in September 2019. JanOne Inc. was founded in 1976 and is headquartered in Las Vegas, Nevada.
- Sector
- Industrials
- Industry
- Waste Management
- Exchange
- NYSE
- Market cap
- $6.7B
- Employees
- 5
- Headquarters
- Las Vegas, NV
- Website
- janone.com
- CEO
- Scott Brinker
- Listed
- March 20, 2026
- P/E
- 0.00
- Dividend yield
- 1.60%
Company financials
- Total assets
- $4B
- Total debt
- $0.00
No annual segmentation.
No geographic segmentation.
News